A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
A phase 1/2 trial of FOLFOX, FLOT, CAPOX in colorectal cancer and pancreatic ductal adenocarcinoma, run by Crossignal Therapeutics, Inc., now recruiting.
Overview
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06598007 by Crossignal Therapeutics, Inc., with 78 participants planned, started 2024-09-20 and due to reach its primary completion in 2027-06-20. Interventions recorded: CT3001, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin). Conditions listed: Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Parti
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junct
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), Pancreatic ductal adenocarcinoma.
- TrialA Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.